LRP2, whose ligand ApoE [21] is known for the risk of Alzheimer’s disease [22, 23], is expressed in brain and facilitates the clearance of the Aβ peptide, that is, the cause of Alzheimer’s disease [24]. Here, LRP2 is linked to early-onset autosomal dominant Alzheimer disease.